4//SEC Filing
Basenese Lou 4
Accession 0001209191-20-024484
CIK 0001681682other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 4:41 PM ET
Size
7.7 KB
Accession
0001209191-20-024484
Insider Transaction Report
Form 4
Basenese Lou
Director
Transactions
- Award
Stock Option (right to buy)
2020-04-09+50,000→ 50,000 totalExercise: $0.70Exp: 2030-04-09→ Common Stock (50,000 underlying) - Award
Common Stock
2020-04-09+41,587→ 41,587 total
Footnotes (4)
- [F1]Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes unvested restricted stock units.
- [F3]Represents a stock option award granted on April 9, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy.
- [F4]This stock option grant becomes exercisable in three equal annual installments beginning April 9, 2021.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001809482
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 4:41 PM ET
- Size
- 7.7 KB